An official website of the United States government Here's how you know

The .gov means it's official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Drugs@FDA: FDA-Approved Drugs

Home | Previous Page

New Drug Application (NDA): 050686
Company: SI PHARMS

Products on NDA 050686

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	TE Code	RLD	RS
CEDAX	CEFTIBUTEN DIHYDRATE	EQ 90MG BASE/5ML Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	FOR SUSPENSION;ORAL	Discontinued	None	Yes	No
CEDAX	CEFTIBUTEN DIHYDRATE	EQ 180MG BASE/5ML Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	FOR SUSPENSION;ORAL	Discontinued	None	Yes	No

Approval Date(s) and History, Letters, Labels, Reviews for NDA 050686

Original Approvals or Tentative Approvals

Action Date	Submission	Action Type	Submission Classification	Review Priority; Orphan Status	Letters, Reviews, Labels, Patient Package Insert	Notes	Url
12/20/1995	ORIG-1	Approval	Type 3 - New Dosage Form	STANDARD		Label is not available on this site.

Supplements

Action Date	Submission	Supplement Categories or Approval Type	Letters, Reviews, Labels, Patient Package Insert	Note	Url
03/11/2011	SUPPL-16	Manufacturing (CMC)	Label (PDF) Letter (PDF)	Please see www.fda.gov/STIC for labeling requirements on susceptibility test interpretive criteria for systemic antibacterial and antifungal drugs.	https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/050686s016lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2011/050686s016ltr.pdf
11/04/2010	SUPPL-15	Labeling	Letter (PDF)	Label is not available on this site.	https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2010/050685s012,050686s015ltr.pdf
02/10/2009	SUPPL-14	Labeling	Label (PDF) Letter (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2009/050685s011,050686s014lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2009/050685s011,050686s014ltr.pdf
01/04/2001	SUPPL-11	Manufacturing (CMC)-Packaging		Label is not available on this site.
05/19/2000	SUPPL-9	Labeling		Label is not available on this site.
10/02/1998	SUPPL-8	Manufacturing (CMC)-Control		Label is not available on this site.
06/15/1998	SUPPL-7	Labeling		Label is not available on this site.
02/16/1999	SUPPL-6	Labeling		Label is not available on this site.
03/03/1998	SUPPL-5	Manufacturing (CMC)-Packaging		Label is not available on this site.
09/03/1997	SUPPL-4	Manufacturing (CMC)		Label is not available on this site.
09/10/1996	SUPPL-3	Manufacturing (CMC)-Control		Label is not available on this site.
05/21/1997	SUPPL-2	Labeling		Label is not available on this site.
10/09/1996	SUPPL-1	Labeling		Label is not available on this site.

Labels for NDA 050686

Action Date	Submission	Supplement Categories or Approval Type	Letters, Reviews, Labels, Patient Package Insert	Note	Url
03/11/2011	SUPPL-16	Manufacturing (CMC)	Label (PDF)	Please see www.fda.gov/STIC for labeling requirements on susceptibility test interpretive criteria for systemic antibacterial and antifungal drugs. This supplement type does not usually require new labeling.	https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/050686s016lbl.pdf
02/10/2009	SUPPL-14	Labeling	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2009/050685s011,050686s014lbl.pdf

Top